4Ashcroft DM, Wan Po AL, Williams HC, et al. Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol, 1999, 141(2): 185-191.
5Savolainen L, Koutinen J, Rouing J, et al. Application of machine visiou to assess involved surface in patients with psoriasis. Br J Dermatol, 1997,137(3):395-400.
6Van De Kerkhof PC. The psoriasis area and severity index and altemative appreaches for the assessment of severity: persisting areas of confusion. Br J Dermatol, 1997, 137:661-662.
7Grlffiths TW et al. Dermatol Clin, 1995; 13 : 739-749.
8Kadunce DP et al. Dermatol Clin, 1995,13:723-734.
1Swoboda SM, Earsing K ,Trauss K, et al. Electronic monitoring and voice prompts improve hand hygiene and decrease nosocomial infection in an intermediate care unit[J]. Crit Care Med,2004,52(2):358-363.
2Jeffes EW 3rd,Mc Cullough JL,Pittelkow MR,et al. Methotrexate thera- py of psoriasis :differential sensitivity of proliferating lymphoid and ep- ithelial cells to the cytotoxic and growth-inhibitory effects of methotrex- ate[J]. J Invest Dermatol, 1995,104(2) : 183-188.
3Menter A,Gotlieb A,Feldman SR,et al. Guidelines of care for the man- agement of psosriasis and psoriatic arthritis :Section 1.Overview of peo- riasis and guide-lines of care for the treatment of peoriasis wish biolog- ics[J]. An "Acad Dermato1,2008,58(5) :826-850.
